Comments
The board of Brooks Laboratories will meet on Tuesday to consider fund-raising through a rights issue of equity shares. If approved, shareholders would eye the rights issue size, price and entitlement ratio. The record date to identify eligible shareholders to participate in the rights issue would also be a key factor. For fiscal 2019, it had reported a loss of ₹14.81 crore on revenues of ₹55.03 crore; for Q4 of FY19, its loss stood at ₹6.94 crore and revenues at ₹15.16 crore.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.